179 related articles for article (PubMed ID: 9042160)
1. Diffuse leiomyomatosis associated with X-linked Alport syndrome: extracellular matrix study using immunohistochemistry and in situ hybridization.
Heidet L; Cai Y; Sado Y; Ninomiya Y; Thorner P; Guicharnaud L; Boye E; Chauvet V; Solal LC; Beziau A; Torres RG; Antignac C; Gubler MC
Lab Invest; 1997 Feb; 76(2):233-43. PubMed ID: 9042160
[TBL] [Abstract][Full Text] [Related]
2. Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis.
Garcia-Torres R; Cruz D; Orozco L; Heidet L; Gubler MC
Nephrologie; 2000; 21(1):9-12. PubMed ID: 10730274
[TBL] [Abstract][Full Text] [Related]
3. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth.
Thielen BK; Barker DF; Nelson RD; Zhou J; Kren SM; Segal Y
Hum Mutat; 2003 Nov; 22(5):419. PubMed ID: 14517961
[TBL] [Abstract][Full Text] [Related]
4. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome.
Ueki Y; Naito I; Oohashi T; Sugimoto M; Seki T; Yoshioka H; Sado Y; Sato H; Sawai T; Sasaki F; Matsuoka M; Fukuda S; Ninomiya Y
Am J Hum Genet; 1998 Feb; 62(2):253-61. PubMed ID: 9463311
[TBL] [Abstract][Full Text] [Related]
6. Clonal overgrowth of esophageal smooth muscle cells in diffuse leiomyomatosis-Alport syndrome caused by partial deletion in COL4A5 and COL4A6 genes.
Oohashi T; Naito I; Ueki Y; Yamatsuji T; Permpoon R; Tanaka N; Naomoto Y; Ninomiya Y
Matrix Biol; 2011 Jan; 30(1):3-8. PubMed ID: 20951201
[TBL] [Abstract][Full Text] [Related]
7. Structure of the human type IV collagen COL4A6 gene, which is mutated in Alport syndrome-associated leiomyomatosis.
Zhang X; Zhou J; Reeders ST; Tryggvason K
Genomics; 1996 May; 33(3):473-9. PubMed ID: 8661006
[TBL] [Abstract][Full Text] [Related]
8. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
[TBL] [Abstract][Full Text] [Related]
9. Comparative distribution of the alpha 1(IV), alpha 5(IV), and alpha 6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients.
Peissel B; Geng L; Kalluri R; Kashtan C; Rennke HG; Gallo GR; Yoshioka K; Sun MJ; Hudson BG; Neilson EG
J Clin Invest; 1995 Oct; 96(4):1948-57. PubMed ID: 7560087
[TBL] [Abstract][Full Text] [Related]
10. Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome.
Sá MJ; Fieremans N; de Brouwer AP; Sousa R; e Costa FT; Brito MJ; Carvalho F; Rodrigues M; de Sousa FT; Felgueiras J; Neves F; Carvalho A; Ramos U; Vizcaíno JR; Alves S; Carvalho F; Froyen G; Oliveira JP
J Med Genet; 2013 Nov; 50(11):745-53. PubMed ID: 23958657
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular diagnosis of Alport syndrome.
Kashtan CE
Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
[TBL] [Abstract][Full Text] [Related]
12. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors.
Droz D; Patey N; Paraf F; Chrétien Y; Gogusev J
Lab Invest; 1994 Nov; 71(5):710-8. PubMed ID: 7526040
[TBL] [Abstract][Full Text] [Related]
13. Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours.
Heidet L; Dahan K; Zhou J; Xu Z; Cochat P; Gould JD; Leppig KA; Proesmans W; Guyot C; Guillot M
Hum Mol Genet; 1995 Jan; 4(1):99-108. PubMed ID: 7711741
[TBL] [Abstract][Full Text] [Related]
14. [Diffuse leiomyomatosis with genital involvement and Alport syndrome. Report of two cases].
Le Bras A; David A; Knipping M; Mensier A; Heidet L; Lopes P
J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):523-8. PubMed ID: 9791580
[TBL] [Abstract][Full Text] [Related]
15. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.
Antignac C; Knebelmann B; Drouot L; Gros F; Deschênes G; Hors-Cayla MC; Zhou J; Tryggvason K; Grünfeld JP; Broyer M
J Clin Invest; 1994 Mar; 93(3):1195-207. PubMed ID: 8132760
[TBL] [Abstract][Full Text] [Related]
16. Absence of the alpha6(IV) chain of collagen type IV in Alport syndrome is related to a failure at the protein assembly level and does not result in diffuse leiomyomatosis.
Zheng K; Harvey S; Sado Y; Naito I; Ninomiya Y; Jacobs R; Thorner PS
Am J Pathol; 1999 Jun; 154(6):1883-91. PubMed ID: 10362815
[TBL] [Abstract][Full Text] [Related]
17. Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome.
Cheong HI; Kashtan CE; Kim Y; Kleppel MM; Michael AF
Lab Invest; 1994 Apr; 70(4):553-7. PubMed ID: 8176894
[TBL] [Abstract][Full Text] [Related]
18. [Detection of large deletions in X linked Alport syndrome using competitive multiplex fluorescence polymerase chain reaction].
Wang F; Zhang YQ; Ding J; Yu LX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):760-767. PubMed ID: 29045953
[TBL] [Abstract][Full Text] [Related]
19. Alport syndrome associated with diffuse leiomyomatosis: COL4A5-COL4A6 deletion associated with a mild form of Alport nephropathy.
Mothes H; Heidet L; Arrondel C; Richter KK; Thiele M; Patzer L; Sado Y; Gubler MC; Antignac C; Scheele J
Nephrol Dial Transplant; 2002 Jan; 17(1):70-4. PubMed ID: 11773466
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle tumors associated with X-linked Alport syndrome: carrier detection in females.
Dahan K; Heidet L; Zhou J; Mettler G; Leppig KA; Proesmans W; David A; Roussel B; Mongeau JG; Gould JM
Kidney Int; 1995 Dec; 48(6):1900-6. PubMed ID: 8587250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
